The Potential of Trastuzumab Deruxtecan as a Tissue Agnostic Drug. Jorgensen JT. Oncology 2023;101:836-842.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Jorgensen JT. The Potential of Trastuzumab Deruxtecan as a Tissue Agnostic Drug. Oncology 2023;101:836-842.
PMID: 37651992